OpenAI CEO's Identity Verification Company Announced Fake Bruno Mars Partnership Due To Mistaken Identity

· ai · Source ↗

TLDR

  • Tools For Humanity announced a Bruno Mars tour partnership that never existed, then corrected it – they’re actually partnering with Thirty Seconds to Mars.

Key Takeaways

  • TFH chief product officer Tiago Sada announced the Bruno Mars partnership during a company event; TFH then published the claim on its website before correcting it.
  • Bruno Mars’ management and Live Nation stated they were never approached by TFH and learned about the alleged partnership only after TFH’s keynote.
  • TFH’s Concert Kit product promises “verified humans” access to VIP tickets and concert experiences via iris-scanning orb identity verification.
  • The actual partnership is with Thirty Seconds to Mars for their 2027 European tour – a Mars/Mars name confusion TFH has not officially explained.
  • TFH, founded 2019 and known for its physical iris-scanning orb, positions itself as a fraud and bot prevention layer for platforms including Live Nation-Ticketmaster.

Hacker News Comment Review

  • The dominant reaction is the self-defeating irony: a company selling identity verification as a core product publicly misidentified a major artist partner, and commenters treated this as a credibility signal, not just a PR flub.
  • Several commenters framed the false announcement as a “hallucinated partnership” – drawing a direct line between AI-adjacent company culture and the kind of confident, unverified assertion the orb is supposedly designed to prevent.
  • One commenter raised the pattern that high-profile identity infrastructure gaffes tend to accelerate government adoption rather than slow it, suggesting TFH’s next move may be official public-sector contracts regardless of this incident.

Notable Comments

  • @_verandaguy: “An outstanding move for a company claiming to sell trust as a service.”
  • @Habgdnv: argues that “trust as PR” for identity infra historically leads to government mandates, not market rejection.

Original | Discuss on HN